Daily FNArena News

Uncertainty is likely to hinder Sigma Pharmaceuticals until a firm earnings base is established after the exit of its major customer.

Peter Switzer of the Switzer Super Report highlights five stocks that are high yield but not as risky as that might imply.

Lithium producer Orocobre is in the spotlight after the Argentine government imposed “temporary” levies on exports, but brokers consider any sell-off overdone.

Michael Gable of Fairmont Equities suggests car accessory distributor Bapcor could dip to an attractive entry point following a solid run.

Incitec Pivot is confident in the FY19 outlook for fertiliser prices while demand for explosives in quarry & construction is robust.

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments.

The severe drought on Australia’s east coast augurs poorly for Graincorp over FY19 but the company has surprised brokers with an upgrade to its FY18 earnings guidance.

Craig Parker of Moat Capital believes the pullback for the ASX200 is healthy and could open the way for a new high.

The outlook for the A-REIT sector is relatively benign, as brokers note portfolio fundamentals are healthy and gearing is generally low. The favoured segment is office while headwinds continue for retail.

AXA Investment Managers’ Mark Tinker explains why trade war tensions alone do not explain current issues facing emerging markets, with a word or two about Australia.